Ubs Asset Management Americas Inc Chroma Dex Corp. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 29,282 shares of CDXC stock, worth $179,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,282
Previous 29,142
0.48%
Holding current value
$179,791
Previous $178,000
0.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
175Shares Held
30.9MCall Options Held
121KPut Options Held
55.6K-
Vanguard Group Inc Valley Forge, PA4.02MShares$24.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.65MShares$10.1 Million4.08% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.44MShares$8.82 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...